Product Information
EXELON 4.6 MG/24HR PATCH is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $22.0229 per EA under NDC 00078050115. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the rivastigmine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4.6 mg/24h
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078050115
Classification
Brand
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Last Updated
6/17/2026
Active Ingredients
RIVASTIGMINEApproval Type
New Drug (NDA)
FDA Application
NDA022083On Market Since
7/6/2007
Pharmacological Classes
Price Statistics
The NADAC for EXELON 4.6 MG/24HR PATCH has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 118.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.0229 per EA |
|---|---|
| All-time high | $22.1170 (Dec 13, 2023) |
| All-time low | $10.0949 (Nov 28, 2013) |
| 52-week high | $22.0229 |
| 52-week low | $21.9387 |
| Median price | $21.8848 |
| Average price | $19.6114 |
| Largest weekly change | +19.9% (Apr 15, 2015) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 92% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EXELON 4.6 MG/24HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for EXELON 4.6 MG/24HR PATCH, manufactured by Novartis Pharmaceuticals Corporation, is $22.0229 per EA (NDC 00078050115), effective Jun 24, 2026.
How has the price of EXELON 4.6 MG/24HR PATCH changed over time?
Over the history we have for it, the NADAC for EXELON 4.6 MG/24HR PATCH has risen 118.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EXELON 4.6 MG/24HR PATCH?
Since Nov 28, 2013, the NADAC for EXELON 4.6 MG/24HR PATCH has ranged from a low of $10.0949 (Nov 28, 2013) to a high of $22.1170 (Dec 13, 2023), with a median of $21.8848 per EA.
Are there cheaper alternatives to EXELON 4.6 MG/24HR PATCH?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RIVASTIGMINE 4.6 MG/24HR PATCH, is $1.8083 per EA — about 92% below EXELON 4.6 MG/24HR PATCH.
Who manufactures EXELON 4.6 MG/24HR PATCH?
EXELON 4.6 MG/24HR PATCH (NDC 00078050115) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification